<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the expression of IL 6 gene in 49 patients, including 21 <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 9 other <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 18 <z:hpo ids='HP_0004808'>acute myeloid leukemias</z:hpo> (11 M2 or M3 and 7 M4 or M5) and 1 case of <z:hpo ids='HP_0011009'>acute</z:hpo> biphenotypic lymphoid monocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>IL 6 was found expressed only in the latter patient and in one patient with M5 <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>DNA analysis by Southern blot revealed no rearrangement in these 2 patients and in 10 of the other patients who showed no IL 6 expression </plain></SENT>
<SENT sid="3" pm="."><plain>These results do not support an autocrine role for IL 6 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> or in other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0004808'>acute myeloid leukemias</z:hpo>, if expressed by leukemic cells, IL 6 seems to be restricted to cases with a monocytic component, although the number of patients was too small to draw any definite conclusion </plain></SENT>
</text></document>